Gdansk
Poland
7
2026-04-09
0
-
These are the the leading inventors for applications assigned to URTESTE S.A.:
URTESTE S.A. based in Gdansk, PL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
COMPOUND - DIAGNOSTIC MARKER FOR OVARIAN CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF OVARIAN CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF OVARIAN CANCER
#2 | 2025-12-11COMPOUND-DIAGNOSTIC MARKER FOR UTERINE BODY CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF UTERINE BODY CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF UTERINE BODY CANCER
#3 | 2025-08-28Compound - diagnostic marker for kidney cancer, method for detecting enzymatic activity, method for diagnosis of kidney cancer, kit comprising the compound, uses of the compound and method for the treatment of kidney cancer
#4 | 2025-06-26COMPOUND - DIAGNOSTIC MARKER FOR INTESTINAL CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF INTESTINAL CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF INTESTINAL CANCER
#5 | 2025-01-02FRET ENZYMATIC SUBSTRATE AND USES THEREOF IN LUNG CANCER
#6 | 2024-10-24FRET ENZYMATIC SUBSTRATE AND USES THEREOF IN LIVER CANCER
#7 | 2023-06-29NOVEL DIAGNOSTIC MARKER FOR PROSTATE CANCER
Also check out URTESTE S.A.'s (Gdansk, Poland) applicant profile with 6 patent applications submitted.
338872 ⎘